Literature DB >> 34649773

Beyond cuts and scrapes: plasmin in malaria and other vector-borne diseases.

Zarna Rajeshkumar Pala1, Medard Ernest1, Brendan Sweeney1, Yeong Je Jeong1, Tales Vicari Pascini1, Thiago Luiz Alves E Silva1, Joel Vega-Rodríguez2.   

Abstract

Plasmodium and other vector-borne pathogens have evolved mechanisms to hijack the mammalian fibrinolytic system to facilitate infection of the human host and the invertebrate vector. Plasmin, the effector protease of fibrinolysis, maintains homeostasis in the blood vasculature by degrading the fibrin that forms blood clots. Plasmin also degrades proteins from extracellular matrices, the complement system, and immunoglobulins. Here, we review some of the mechanisms by which vector-borne pathogens interact with components of the fibrinolytic system and co-opt its functions to facilitate transmission and infection in the host and the vector. Further, we discuss innovative strategies beyond conventional therapeutics that could be developed to target the interaction of vector-borne pathogens with the fibrinolytic proteins and prevent their transmission. Published by Elsevier Ltd.

Entities:  

Keywords:  fibrinolysis; malaria; plasmin; vector-borne diseases

Mesh:

Substances:

Year:  2021        PMID: 34649773      PMCID: PMC8758534          DOI: 10.1016/j.pt.2021.09.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  84 in total

1.  Leishmania mexicana: LACK (Leishmania homolog of receptors for activated C-kinase) is a plasminogen binding protein.

Authors:  Amaranta Gómez-Arreaza; Héctor Acosta; Ximena Barros-Álvarez; Juan L Concepción; Fernando Albericio; Luisana Avilan
Journal:  Exp Parasitol       Date:  2011-01-25       Impact factor: 2.011

2.  Plasmodium ookinetes coopt mammalian plasminogen to invade the mosquito midgut.

Authors:  Anil K Ghosh; Isabelle Coppens; Henrik Gårdsvoll; Michael Ploug; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

3.  Fighting malaria with engineered symbiotic bacteria from vector mosquitoes.

Authors:  Sibao Wang; Anil K Ghosh; Nicholas Bongio; Kevin A Stebbings; David J Lampe; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

4.  Plasmodium falciparum proteases hydrolyze plasminogen, generating angiostatin-like fragments.

Authors:  Pollyana M S Melo; Piero Bagnaresi; Thaysa Paschoalin; Izaura Y Hirata; Marcos L Gazarini; Adriana K Carmona
Journal:  Mol Biochem Parasitol       Date:  2014-02-03       Impact factor: 1.759

5.  Tick salivary cystatin sialostatin L2 suppresses IFN responses in mouse dendritic cells.

Authors:  J Lieskovská; J Páleníková; J Širmarová; J Elsterová; M Kotsyfakis; A Campos Chagas; E Calvo; D Růžek; J Kopecký
Journal:  Parasite Immunol       Date:  2015-02       Impact factor: 2.280

6.  Borrelia outer surface protein C is capable of human fibrinogen binding.

Authors:  Paulina Bierwagen; Kamil Szpotkowski; Mariusz Jaskolski; Anna Urbanowicz
Journal:  FEBS J       Date:  2019-03-23       Impact factor: 5.542

7.  Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.

Authors:  T Sasaki; T Morita; S Iwanaga
Journal:  J Biochem       Date:  1986-06       Impact factor: 3.387

8.  The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis.

Authors:  J A Gebbia; J C Monco; J L Degen; T H Bugge; J L Benach
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers.

Authors:  J L Coleman; T J Sellati; J E Testa; R R Kew; M B Furie; J L Benach
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Interaction of Trypanosoma evansi with the plasminogen-plasmin system.

Authors:  Héctor Acosta; Rocío Rondón-Mercado; Luisana Avilán; Juan Luis Concepción
Journal:  Vet Parasitol       Date:  2016-07-14       Impact factor: 2.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.